Centro de Investigación en Medicina Molecular e Enfermidades Crónicas (CIMUS)
Centro singular
![Foto de Centro de Investigación en Medicina Molecular e Enfermidades Crónicas (CIMUS)](/img/noimage.png)
![Foto de Christie Hospital NHS Foundation Trust](/img/noimage_org.png)
Christie Hospital NHS Foundation Trust
Mánchester, Reino UnidoPublicacións en colaboración con investigadores/as de Christie Hospital NHS Foundation Trust (7)
2022
2020
-
Divergent mutational processes distinguish hypoxic and normoxic tumours
Nature Communications, Vol. 11, Núm. 1
2017
-
Gefitinib and EGFR gene copy number aberrations in esophageal cancer
Journal of Clinical Oncology, Vol. 35, Núm. 20, pp. 2279-2287
2014
-
Gefitinib for oesophageal cancer progressing after chemotherapy (COG): A phase 3, multicentre, double-blind, placebo-controlled randomised trial
The Lancet Oncology, Vol. 15, Núm. 8, pp. 894-904
-
Gemcitabine and capecitabine with or without telomerase peptide vaccine GV1001 in patients with locally advanced or metastatic pancreatic cancer (TeloVac): An open-label, randomised, phase 3 trial
The Lancet Oncology, Vol. 15, Núm. 8, pp. 829-840
-
Phase II trial of cetuximab and conformal radiotherapy only in locally advanced pancreatic cancer with concurrent tissue sampling feasibility study
Translational Oncology, Vol. 7, Núm. 1, pp. 55-64